A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)

Abstract

We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease . Rapid global health authorities' responses are now in course and international scientific collaboration is urgently need. Previous outbreaks experiences with similar viral agents have increased the capacity to containment and control of these recurrent health menaces. Un nuevo virus zoonótico emergente de preocupación: el Coronavirus novel 2019Resumen Revisamos aquí el origen, características del brote y la epidemiología del nuevo Coronavirus (2019nCoV) responsable de una nueva enfermedad por coronavirus . Una rápida respuesta de las autoridades de salud mundiales está en marcha y se ha hecho un llamado urgente para colaboración científica internacional. Las lecciones aprendidas de brotes previos con agentes virales similares han aumentado las capacidades para contener y controlar estas amenazas recurrentes a la salud global.

2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission

“…The first symptoms observed clinically were fever, fatigue, and dry cough, with symptoms ranging from mild to severe (19). Currently, the protocol developed by the Centers for Disease Control and Prevention (CDC) for diagnosis (20) is a combination of clinical observation of symptoms and a positive result for the presence of the virus using real-time PCR (rt-PCR) (21).…”

Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain

“…For the moment of the arrival of these cases, the last on March 15, 2020, there were 7,988 cases in Spain. That issue has been a common trend in Latin America now, imported cases from Italy and Spain [27,41,42]. This highlights the relevance of the spread of the COVID-19 due to population movements that has affected Bolivia, but also countries in South America, and most in the Latin American and the Caribbean region.…”

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

“…As expected, several similarities and differences in the epidemiology, clinical features, and management of SARS, MERS, and COVID have been identified [3][4][5][20][21][22][23]. These are enveloped positive-strand RNA viruses isolated from bats that share sequence homology with isolates from humans, suggesting bats as natural hosts and reservoirs [9,[24][25][26][27]. Although the clinical picture of SARS, MERS, and COVID-19 seems to be similar, differences were noted [4,5,21,28] are apparent since early reports.…”

“…The SARS-CoV-2, taxonomically, is currently part of the species of the SARS-related coronaviruses that belong to the subgenus Sarbecovirus. Together with the subgenuses Embecovirus, Hibecovirus, Merbecovirus, and Nobecovirus, that are part of the genus Betacoronavirus (order Nidovirales; suborder Cornidovirineae; family Coronaviridae; subfamily Coronavirinae) [8][9][10][11][12][13][14].…”